Regina Wallace-Jones, the CEO of ActBlue, is scheduled to testify before the House Administration Committee on June 10, 2026, as part of an ongoing investigation into alleged donor fraud involving the group. This hearing follows accusations that ActBlue misled Congress regarding its practices for vetting overseas donors. ActBlue representatives have denied these allegations, asserting that the investigation is politically motivated.
House Committee Chairman Bryan Steil has emphasized the investigation's aim to prevent foreign money from influencing U.S. elections. Wallace-Jones's testimony will be her first public response to the fraud claims. The committee has scrutinized ActBlue since 2023 over its fraud prevention practices, particularly concerning donations from nonresident foreign nationals, which are generally prohibited.
The investigation intensified after reports indicated discrepancies between ActBlue's statements to Congress and its internal practices. Some employees of ActBlue invoked their Fifth Amendment rights during previous testimonies. The committee has also requested interviews with five members of ActBlue's Board of Directors to discuss their roles in the organization's response to congressional inquiries.